- Citations, last 5 years
- 680
- Works, last 5 years
- 184
- h-index
- 83
- Scientists listed
- 13
- Grants since 2016
- 1 402
Grants received
2024–2027 · research · R33
Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism
Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health
2024–2029 · research · R01
Primate inhibitory neurons in hippocampal CA3-CA1 intrinsic circuits
Helen Barbas · Charles River Associates · funded by National Institutes of Health
2024–2028 · research · R01
Intracardiac beating heart tricuspid valve repair via robotics.
Tommaso Ranzani · Charles River Associates · funded by National Institutes of Health
2024–2026 · cooperative agreement · UG3
Expanding Inclusion of All Subjects for Ultra-High Density Wearable fNIRS in the Everyday World
David A Boas · Charles River Associates · funded by National Institutes of Health
2024–2026 · fellowship · F31
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Amber Normann · Charles River Associates · funded by National Institutes of Health
2024–2025 · fellowship · F31
Bilingualism as a cognitive reserve factor: the behavioral and neural underpinnings of cognitive control in bilingual patients with aphasia
Erin Carpenter · Charles River Associates · funded by National Institutes of Health
2024–2027 · research · R21
Telehealth Exercise and Mindfulness of Pain in knee Osteoarthritis (TEMPO): A digital Feasibility Study
Deepak Kumar · Charles River Associates · funded by National Institutes of Health
2024–2029 · research · R01
Local and Long-Range Cortical Circuits Underlying Tactile Perception
Jerry L Chen · Charles River Associates · funded by National Institutes of Health
2024–2025 · fellowship · F31
Assessment of real-time reading comprehension in bilinguals with aphasia
Michael David Scimeca · Charles River Associates · funded by National Institutes of Health
2024–2027 · research · R01
Super-sensitive vibrational imaging by synergic development of instruments and probes
Daniela Buccella · Charles River Associates · funded by National Institutes of Health
2024–2026 · fellowship · F99
Genetic and Neural Sources of Individual Differences in Goal-directed Learning in Health and Disease
Alanna Carey · Charles River Associates · funded by National Institutes of Health
2024–2029 · career development · K23
Dual language input, semantic structure and word learning in typically developing and late talking bilingual children
Kimberly Crespo · Charles River Associates · funded by National Institutes of Health
2024–2027 · research · R21
Nanotherapeutics for Targeted Glial Cell Drug Delivery
Timothy Mark O'Shea · Charles River Associates · funded by National Institutes of Health
2024–2029 · training · T32
Graduate Training at the Interface of Neuroscience, Optical Engineering and Data Science
David A Boas · Charles River Associates · funded by National Institutes of Health
2024–2029 · research · R35
Regulating parenchymal repair in wound healing
Timothy Mark O'Shea · Charles River Associates · funded by National Institutes of Health
2024–2026 · fellowship · F31
Glycopolymer Biomaterials for Regulating Adaptive Reprogramming in Glia
Eric Dubois · Charles River Associates · funded by National Institutes of Health
2024–2027 · fellowship · F31
Examining Sex-Specific Effects on White Matter Integrity and Brain Function in Familial Alzheimer's Disease and Vascular Dementia
Averi Jordin Giudicessi · Charles River Associates · funded by National Institutes of Health
2024–2029 · research · R01
Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2024–2026 · fellowship · F31
Development of a Tunable Protein Release Hydrogel for the Enhancement of CAR T cell Activity
Sarah C Adams · Charles River Associates · funded by National Institutes of Health
2024–2028 · research · R01
Hip structure and function in young female athletes
Cara L Lewis · Charles River Associates · funded by National Institutes of Health
2024–2027 · fellowship · F31
Development and characterization of self-amplifying RNA Lipid Nanoparticles for potent and multiplex gene expression in solid tumors
Arun Kannoth Nambiar · Charles River Associates · funded by National Institutes of Health
2024–2025 · fellowship · F32
Longitudinal trajectories of white matter and reading development in bilingual children
Juliana Ronderos · Charles River Associates · funded by National Institutes of Health
2024–2027 · research · R00
Assessing Parenting at the Momentary Level to Understand Parenting Behaviors that Contribute to Improved Treatment Outcomes for Youth with Co-Occurring Disorders
Samuel Noah Meisel · Charles River Associates · funded by National Institutes of Health
2024–2026 · fellowship · F31
Molecular evolution of synthetic probes for orphan GPCRs
Ari Benjamin Fitzsimmons · Charles River Associates · funded by National Institutes of Health
2024–2029 · research · R01
Investigating the Effect of Arousal on Visual Processing
Janneke Jehee · Charles River Associates · funded by National Institutes of Health
2024–2029 · research · R01
A Relaxin-loaded Hydrogel for the Treatment of Hypertrophic Scars
Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health
2024–2028 · research · R01
Engineering recombinase circuits for cellular diagnostic devices
Wilson Wong · Charles River Associates · funded by National Institutes of Health
2024–2029 · fellowship · F30
A Bio-orthogonal Targeting System for Precision Drug Delivery to Vascular Endothelium in Transplanted Organs
Aria Pearlman Morales · Charles River Associates · funded by National Institutes of Health
2024–2026 · career development · K99
Uncovering the Molecular Determinants of Cell Type-Specific Connectivity
Maria Victoria Moya · Charles River Associates · funded by National Institutes of Health
2024–2025 · fellowship · F31
Neural Circuit Dynamics Underlying Perceptual Decision Making in the Macaque Dorsolateral Prefrontal Cortex
Eric Kenji Lee · Charles River Associates · funded by National Institutes of Health
2023–2028 · fellowship · F30
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
Linzheng Shi · Charles River Associates · funded by National Institutes of Health
2023–2026 · fellowship · F31
Articulatory and prosodic sensorimotor adaptation in speaker-listener interactions
Kimberly Dahl · Charles River Associates · funded by National Institutes of Health
2023–2026 · research · R21
Spatio-temporal mechanistic modeling of whole-cell tumor metabolism
Ilija Dukovski · Charles River Associates · funded by National Institutes of Health
2023–2028 · research · R01
Computational modeling of language impairment and control in bilingual individuals with post-stroke aphasia and neurodegenerative disorders
Swathi Kiran · Charles River Associates · funded by National Institutes of Health
2023–2024 · fellowship · F32
Synthetic morphogenesis to recapitulate multicellular airway branching patterns
Ian S Kinstlinger · Charles River Associates · funded by National Institutes of Health
2023–2026 · research · R21
Feasibility and outcome measures for infants with Down syndrome: Advancing clinical trial readiness for a harness-based mobility intervention
Nicole Baumer · Charles River Associates · funded by National Institutes of Health
2023–2028 · training · T32
Predoctoral Training in Bioinformatics and Computational Biology
Gary E. Benson · Charles River Associates · funded by National Institutes of Health
2023–2028 · research · R01
A Modular Framework for Data-Driven Neurogenetics to Predict Complex and Multidimensional Autistic Phenotypes
Archana Venkataraman · Charles River Associates · funded by National Institutes of Health
2023–2028 · research · R01
Personalized Synchronization of Cortical Rhythms to Improve Memory in Alzheimer's Disease
Robert Reinhart · Charles River Associates · funded by National Institutes of Health
2023–2027 · research · R01
Extending Reach, Accuracy, and Therapeutic Capabilities: A Soft Robot for Peripheral Early-Stage Lung Cancer
Sheila Russo · Charles River Associates · funded by National Institutes of Health